Skip Header

You are using a version of browser that may not display all the features of this website. Please consider upgrading your browser.

UniProtKB - P02545 (LMNA_HUMAN)

Protein

Prelamin-A/C

Gene

LMNA

Organism
Homo sapiens (Human)
Status
Reviewed-Annotation score:

Annotation score:5 out of 5

<p>The annotation score provides a heuristic measure of the annotation content of a UniProtKB entry or proteome. This score <strong>cannot</strong> be used as a measure of the accuracy of the annotation as we cannot define the ‘correct annotation’ for any given protein.<p><a href='/help/annotation_score' target='_top'>More...</a></p>-Experimental evidence at protein leveli <p>This indicates the type of evidence that supports the existence of the protein. Note that the ‘protein existence’ evidence does not give information on the accuracy or correctness of the sequence(s) displayed.<p><a href='/help/protein_existence' target='_top'>More...</a></p>

<p>This section provides any useful information about the protein, mostly biological knowledge.<p><a href='/help/function_section' target='_top'>More...</a></p>Functioni

Lamins are components of the nuclear lamina, a fibrous layer on the nucleoplasmic side of the inner nuclear membrane, which is thought to provide a framework for the nuclear envelope and may also interact with chromatin. Lamin A and C are present in equal amounts in the lamina of mammals. Plays an important role in nuclear assembly, chromatin organization, nuclear membrane and telomere dynamics. Required for normal development of peripheral nervous system and skeletal muscle and for muscle satellite cell proliferation (PubMed:10080180, PubMed:22431096, PubMed:10814726, PubMed:11799477, PubMed:18551513). Required for osteoblastogenesis and bone formation (PubMed:12075506, PubMed:15317753, PubMed:18611980). Also prevents fat infiltration of muscle and bone marrow, helping to maintain the volume and strength of skeletal muscle and bone (PubMed:10587585). Required for cardiac homeostasis (PubMed:10580070, PubMed:12927431, PubMed:18611980, PubMed:23666920).12 Publications
Prelamin-A/C can accelerate smooth muscle cell senescence. It acts to disrupt mitosis and induce DNA damage in vascular smooth muscle cells (VSMCs), leading to mitotic failure, genomic instability, and premature senescence.

Miscellaneous

There are three types of lamins in human cells: A, B, and C.
The structural integrity of the lamina is strictly controlled by the cell cycle, as seen by the disintegration and formation of the nuclear envelope in prophase and telophase, respectively.

Sites

Feature keyPosition(s)DescriptionActionsGraphical viewLength
<p>This subsection describes interesting single amino acid sites on the sequence that are not defined in any other subsection. This subsection can be displayed in different sections (‘Function’, ‘PTM / Processing’, ‘Pathology and Biotech’) according to its content.<p><a href='/help/site' target='_top'>More...</a></p>Sitei266Heptad change of phase1
Sitei325StutterBy similarity1
Sitei330Heptad change of phase1

<p>The <a href="http://www.geneontology.org/">Gene Ontology (GO)</a> project provides a set of hierarchical controlled vocabulary split into 3 categories:<p><a href='/help/gene_ontology' target='_top'>More...</a></p>GO - Molecular functioni

  • identical protein binding Source: IntAct
  • structural molecule activity Source: UniProtKB
View the complete GO annotation on QuickGO ...

GO - Biological processi

View the complete GO annotation on QuickGO ...

Enzyme and pathway databases

Reactome - a knowledgebase of biological pathways and processes

More...Reactomei		R-HSA-1221632 Meiotic synapsis
R-HSA-2993913 Clearance of Nuclear Envelope Membranes from Chromatin
R-HSA-2995383 Initiation of Nuclear Envelope Reformation
R-HSA-352238 Breakdown of the nuclear lamina
R-HSA-381038 XBP1(S) activates chaperone genes
R-HSA-4419969 Depolymerisation of the Nuclear Lamina
R-HSA-6802952 Signaling by BRAF and RAF fusions
R-HSA-8862803 Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models

SIGNOR Signaling Network Open Resource

More...SIGNORi		P02545

<p>This section provides information about the protein and gene name(s) and synonym(s) and about the organism that is the source of the protein sequence.<p><a href='/help/names_and_taxonomy_section' target='_top'>More...</a></p>Names & Taxonomyi

<p>This subsection of the <a href="http://www.uniprot.org/help/names_and_taxonomy_section">Names and taxonomy</a> section provides an exhaustive list of all names of the protein, from commonly used to obsolete, to allow unambiguous identification of a protein.<p><a href='/help/protein_names' target='_top'>More...</a></p>Protein namesi
Recommended name:
Prelamin-A/C
Cleaved into the following chain:
Lamin-A/C
Alternative name(s):
70 kDa lamin
Renal carcinoma antigen NY-REN-32
<p>This subsection of the <a href="http://www.uniprot.org/help/names_and_taxonomy_section">Names and taxonomy</a> section indicates the name(s) of the gene(s) that code for the protein sequence(s) described in the entry. Four distinct tokens exist: ‘Name’, ‘Synonyms’, ‘Ordered locus names’ and ‘ORF names’.<p><a href='/help/gene_name' target='_top'>More...</a></p>Gene namesi
Name:LMNA
Synonyms:LMN1
<p>This subsection of the <a href="http://www.uniprot.org/help/names_and_taxonomy_section">Names and taxonomy</a> section provides information on the name(s) of the organism that is the source of the protein sequence.<p><a href='/help/organism-name' target='_top'>More...</a></p>OrganismiHomo sapiens (Human)
<p>This subsection of the <a href="http://www.uniprot.org/help/names_and_taxonomy_section">Names and taxonomy</a> section shows the unique identifier assigned by the NCBI to the source organism of the protein. This is known as the ‘taxonomic identifier’ or ‘taxid’.<p><a href='/help/taxonomic_identifier' target='_top'>More...</a></p>Taxonomic identifieri9606 [NCBI]
<p>This subsection of the <a href="http://www.uniprot.org/help/names_and_taxonomy_section">Names and taxonomy</a> section contains the taxonomic hierarchical classification lineage of the source organism. It lists the nodes as they appear top-down in the taxonomic tree, with the more general grouping listed first.<p><a href='/help/taxonomic_lineage' target='_top'>More...</a></p>Taxonomic lineageiEukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo
<p>This subsection of the <a href="http://www.uniprot.org/help/names_and_taxonomy_section">Names and taxonomy</a> section is present for entries that are part of a <a href="http://www.uniprot.org/proteomes">proteome</a>, i.e. of a set of proteins thought to be expressed by organisms whose genomes have been completely sequenced.<p><a href='/help/proteomes_manual' target='_top'>More...</a></p>Proteomesi
  • UP000005640 <p>A UniProt <a href="http://www.uniprot.org/manual/proteomes_manual">proteome</a> can consist of several components. <br></br>The component name refers to the genomic component encoding a set of proteins.<p><a href='/help/proteome_component' target='_top'>More...</a></p> Componenti: Chromosome 1

Organism-specific databases

Eukaryotic Pathogen Database Resources

More...EuPathDBi		HostDB:ENSG00000160789.19

Human Gene Nomenclature Database

More...HGNCi		HGNC:6636 LMNA

Online Mendelian Inheritance in Man (OMIM)

More...MIMi		150330 gene

neXtProt; the human protein knowledge platform

More...neXtProti		NX_P02545

<p>This section provides information on the location and the topology of the mature protein in the cell.<p><a href='/help/subcellular_location_section' target='_top'>More...</a></p>Subcellular locationi

Extracellular region or secreted Cytosol Plasma membrane Cytoskeleton Lysosome Endosome Peroxisome ER Golgi apparatus Nucleus Mitochondrion Manual annotation Automatic computational assertionGraphics by Christian Stolte; Source: COMPARTMENTS

<p>UniProtKB Keywords constitute a <a href="http://www.uniprot.org/keywords">controlled vocabulary</a> with a hierarchical structure. Keywords summarise the content of a UniProtKB entry and facilitate the search for proteins of interest.<p><a href='/help/keywords' target='_top'>More...</a></p>Keywords - Cellular componenti

Intermediate filament, Nucleus

<p>This section provides information on the disease(s) and phenotype(s) associated with a protein.<p><a href='/help/pathology_and_biotech_section' target='_top'>More...</a></p>Pathology & Biotechi

<p>This subsection of the ‘Pathology and Biotech’ section provides information on the disease(s) associated with genetic variations in a given protein. The information is extracted from the scientific literature and diseases that are also described in the <a href="http://www.ncbi.nlm.nih.gov/sites/entrez?db=omim">OMIM</a> database are represented with a <a href="http://www.uniprot.org/diseases">controlled vocabulary</a> in the following way:<p><a href='/help/involvement_in_disease' target='_top'>More...</a></p>Involvement in diseasei

Emery-Dreifuss muscular dystrophy 2, autosomal dominant (EDMD2)15 Publications
The disease is caused by mutations affecting the gene represented in this entry.
Disease descriptionA form of Emery-Dreifuss muscular dystrophy, a degenerative myopathy characterized by weakness and atrophy of muscle without involvement of the nervous system, early contractures of the elbows, Achilles tendons and spine, and cardiomyopathy associated with cardiac conduction defects.
See also OMIM:181350
Feature keyPosition(s)DescriptionActionsGraphical viewLength
<p>This subsection of the ‘Sequence’ section describes natural variant(s) of the protein sequence.<p><a href='/help/variant' target='_top'>More...</a></p>Natural variantiVAR_03974625R → G in EDMD2. 1 PublicationCorresponds to variant dbSNP:rs58327533EnsemblClinVar.1
Natural variantiVAR_03974725R → P in EDMD2; mis-localized in the nucleus; causes nuclear deformations and LMNB1 redistribution. 2 PublicationsCorresponds to variant dbSNP:rs61578124EnsemblClinVar.1
Natural variantiVAR_03974932Missing in EDMD2; abnormal nuclear localization in a honeycomb expression pattern in about 11% of cultured skin fibroblasts from heterozygous patients; no effect on protein level. 3 Publications1
Natural variantiVAR_03975133E → G in EDMD2. 1 PublicationCorresponds to variant dbSNP:rs267607614EnsemblClinVar.1
Natural variantiVAR_03975235L → V in EDMD2. 1 PublicationCorresponds to variant dbSNP:rs56694480EnsemblClinVar.1
Natural variantiVAR_03975343A → T in EDMD2. 1 PublicationCorresponds to variant dbSNP:rs60446065EnsemblClinVar.1
Natural variantiVAR_00997145Y → C in EDMD2. 2 PublicationsCorresponds to variant dbSNP:rs58436778EnsemblClinVar.1
Natural variantiVAR_03975450R → S in EDMD2. 1 PublicationCorresponds to variant dbSNP:rs59931416EnsemblClinVar.1
Natural variantiVAR_03975663I → N in EDMD2. 3 PublicationsCorresponds to variant dbSNP:rs57793737EnsemblClinVar.1
Natural variantiVAR_00997463I → S in EDMD2; no effect on protein level; no obvious effect on nuclear morphology in cultured skin fibroblasts from heterozygous patients. 2 PublicationsCorresponds to variant dbSNP:rs57793737EnsemblClinVar.1
Natural variantiVAR_03975765E → G in EDMD2. 1 Publication1
Natural variantiVAR_009976112Missing in EDMD2. 2 Publications1
Natural variantiVAR_017657133R → P in EDMD2. 1 PublicationCorresponds to variant dbSNP:rs60864230EnsemblClinVar.1
Natural variantiVAR_039760140L → P in EDMD2. 2 PublicationsCorresponds to variant dbSNP:rs60652225EnsemblClinVar.1
Natural variantiVAR_039762150T → P in EDMD2. 2 PublicationsCorresponds to variant dbSNP:rs58917027EnsemblClinVar.1
Natural variantiVAR_064962189R → P in EDMD2; found also in a patient with limb-girdle muscular dystrophy; sporadic. 1 PublicationCorresponds to variant dbSNP:rs267607643EnsemblClinVar.1
Natural variantiVAR_064963190R → RR in EDMD2. 1 Publication1
Natural variantiVAR_039766196 – 199RLQT → S in EDMD2. 1 Publication4
Natural variantiVAR_064964206F → L in EDMD2. 1 PublicationCorresponds to variant dbSNP:rs267607629EnsemblClinVar.1
Natural variantiVAR_039769222H → P in EDMD2. 1 PublicationCorresponds to variant dbSNP:rs58034145EnsemblClinVar.1
Natural variantiVAR_009979222H → Y in EDMD2. 1 PublicationCorresponds to variant dbSNP:rs28928901EnsemblClinVar.1
Natural variantiVAR_039771232G → E in EDMD2. 1 PublicationCorresponds to variant dbSNP:rs57207746EnsemblClinVar.1
Natural variantiVAR_039772248L → P in EDMD2. 1 PublicationCorresponds to variant dbSNP:rs58850446EnsemblClinVar.1
Natural variantiVAR_009980249R → Q in EDMD2; no obvious effect on nuclear morphology in cultured skin fibroblasts from heterozygous patients; no effect on protein level. 9 PublicationsCorresponds to variant dbSNP:rs59332535EnsemblClinVar.1
Natural variantiVAR_009981261Missing in EDMD2. 3 Publications1
Natural variantiVAR_039774267Y → C in EDMD2. 1 PublicationCorresponds to variant dbSNP:rs57048196EnsemblClinVar.1
Natural variantiVAR_064965268S → P in EDMD2. 1 PublicationCorresponds to variant dbSNP:rs267607630EnsemblClinVar.1
Natural variantiVAR_064966271L → P in EDMD2. 1 PublicationCorresponds to variant dbSNP:rs267607641EnsemblClinVar.1
Natural variantiVAR_009982294Q → P in EDMD2. 2 PublicationsCorresponds to variant dbSNP:rs61616775EnsemblClinVar.1
Natural variantiVAR_064967295S → P in EDMD2. 1 PublicationCorresponds to variant dbSNP:rs267607633EnsemblClinVar.1
Natural variantiVAR_064968303S → P in EDMD2. 1 PublicationCorresponds to variant dbSNP:rs61527854EnsemblClinVar.1
Natural variantiVAR_009983336R → Q in EDMD2. 2 PublicationsCorresponds to variant dbSNP:rs58105277EnsemblClinVar.1
Natural variantiVAR_009984343R → Q in EDMD2. 1 PublicationCorresponds to variant dbSNP:rs61177390EnsemblClinVar.1
Natural variantiVAR_064969355Missing in EDMD2. 1 Publication1
Natural variantiVAR_064970361E → K in EDMD2. 1 PublicationCorresponds to variant dbSNP:rs267607634EnsemblClinVar.1
Natural variantiVAR_009986371M → K in EDMD2; dramatically aberrant localization with decreased nuclear rim staining and formation of intranuclear foci; distribution of endogenous LMNA, LMNB1 and LMNB2 are altered in cells expressing this mutant; causes an increased loss of endogenous EMD from the nuclear envelope; interacts with itself and with wild-type LMNA and LMNB1; no decrease in the stability compared with wild-type. 2 PublicationsCorresponds to variant dbSNP:rs59653062EnsemblClinVar.1
Natural variantiVAR_009987386R → K in EDMD2; dramatically aberrant localization with decreased nuclear rim staining and formation of intranuclear foci; distribution of endogenous LMNA, LMNB1 and LMNB2 are altered in cells expressing this mutant; causes an increased loss of endogenous EMD from the nuclear envelope; interacts with itself and with wild-type LMNA and LMNB1; no decrease in the stability compared with wild-type. 4 PublicationsCorresponds to variant dbSNP:rs267607545EnsemblClinVar.1
Natural variantiVAR_072818401R → C in EDMD2; abnormal nuclear localization in a honeycomb expression pattern in about 22% of cultured skin fibroblasts from heterozygous patients; enhances the interaction with SYNE2; no effect on nuclear localization; no effect on protein level. 3 PublicationsCorresponds to variant dbSNP:rs61094188EnsemblClinVar.1
Natural variantiVAR_039780446D → V in EDMD2. 1 PublicationCorresponds to variant dbSNP:rs58541611EnsemblClinVar.1
Natural variantiVAR_064971449G → D in EDMD2. 1 PublicationCorresponds to variant dbSNP:rs267607637EnsemblClinVar.1
Natural variantiVAR_009988453R → W in EDMD2; abnormal nuclear localization; forms nuclear foci in about 8% of cultured skin fibroblasts from heterozygous patients; interacts with itself and with wild-type LMNA and LMNB1; no effect on protein level. 8 PublicationsCorresponds to variant dbSNP:rs58932704EnsemblClinVar.1
Natural variantiVAR_064972454L → P in EDMD2. 1 PublicationCorresponds to variant dbSNP:rs267607638EnsemblClinVar.1
Natural variantiVAR_039781456N → I in EDMD2; mislocalized in the nucleus; does not alter nuclear size or shape. 2 PublicationsCorresponds to variant dbSNP:rs60992550EnsemblClinVar.1
Natural variantiVAR_039782456N → K in EDMD2. 1 PublicationCorresponds to variant dbSNP:rs61235244EnsemblClinVar.1
Natural variantiVAR_064973461D → Y in EDMD2. 1 PublicationCorresponds to variant dbSNP:rs267607642EnsemblClinVar.1
Natural variantiVAR_064974467W → R in EDMD2. 1 PublicationCorresponds to variant dbSNP:rs267607639EnsemblClinVar.1
Natural variantiVAR_009990469I → T in EDMD2. 1 PublicationCorresponds to variant dbSNP:rs57394692EnsemblClinVar.1
Natural variantiVAR_039784520W → S in EDMD2; interacts with itself and with wild-type LMNA and LMNB1; no decrease in the stability compared with wild-type. 2 PublicationsCorresponds to variant dbSNP:rs58362413EnsemblClinVar.1
Natural variantiVAR_009996528T → K in EDMD2; interacts with itself and with wild-type LMNA and LMNB1; no decrease in the stability compared with wild-type. 4 PublicationsCorresponds to variant dbSNP:rs57629361EnsemblClinVar.1
Natural variantiVAR_039785528T → R in EDMD2. 2 PublicationsCorresponds to variant dbSNP:rs57629361EnsemblClinVar.1
Natural variantiVAR_009997530L → P in EDMD2; interacts with itself and with wild-type LMNA and LMNB1; reduced binding to SUN1; no decrease in the stability compared with wild-type. 3 PublicationsCorresponds to variant dbSNP:rs60934003EnsemblClinVar.1
Natural variantiVAR_039787541R → H in EDMD2. 1 PublicationCorresponds to variant dbSNP:rs61444459EnsemblClinVar.1
Natural variantiVAR_064975541R → P in EDMD2; mis-localized in the nucleus; does not alter nuclear size or shape. 1 PublicationCorresponds to variant dbSNP:rs61444459EnsemblClinVar.1
Natural variantiVAR_064976602G → S in EDMD2. 1 PublicationCorresponds to variant dbSNP:rs60662302EnsemblClinVar.1
Natural variantiVAR_039791624R → H in EDMD2. 1 PublicationCorresponds to variant dbSNP:rs13768EnsemblClinVar.1
Emery-Dreifuss muscular dystrophy 3, autosomal recessive (EDMD3)2 Publications
The disease is caused by mutations affecting the gene represented in this entry.
Disease descriptionA form of Emery-Dreifuss muscular dystrophy, a degenerative myopathy characterized by weakness and atrophy of muscle without involvement of the nervous system, early contractures of the elbows, Achilles tendons and spine, and cardiomyopathy associated with cardiac conduction defects.
See also OMIM:616516
Feature keyPosition(s)DescriptionActionsGraphical viewLength
Natural variantiVAR_07656224T → S in EDMD3. 1 Publication1
Natural variantiVAR_067697225R → Q in EDMD3. 1 PublicationCorresponds to variant dbSNP:rs199474724EnsemblClinVar.1
Cardiomyopathy, dilated 1A (CMD1A)17 Publications
The disease is caused by mutations affecting the gene represented in this entry.
Disease descriptionA disorder characterized by ventricular dilation and impaired systolic function, resulting in congestive heart failure and arrhythmia. Patients are at risk of premature death.
See also OMIM:115200
Feature keyPosition(s)DescriptionActionsGraphical viewLength
Natural variantiVAR_00997585L → R in CMD1A; interacts with itself and with wild-type LMNA and LMNB1; no decrease in the stability compared with wild-type. 2 PublicationsCorresponds to variant dbSNP:rs28933090EnsemblClinVar.1
Natural variantiVAR_03975889R → L in CMD1A; dramatically aberrant localization with almost no nuclear rim staining and formation of intranuclear foci. 2 PublicationsCorresponds to variant dbSNP:rs59040894EnsemblClinVar.1
Natural variantiVAR_06725792L → F in CMD1A. 1 PublicationCorresponds to variant dbSNP:rs267607560EnsemblClinVar.1
Natural variantiVAR_03975997K → E in CMD1A. 1 PublicationCorresponds to variant dbSNP:rs59065411EnsemblClinVar.1
Natural variantiVAR_070174101R → P in CMD1A; dramatically aberrant localization with almost no nuclear rim staining and formation of intranuclear foci. 1 PublicationCorresponds to variant dbSNP:rs267607568EnsemblClinVar.1
Natural variantiVAR_039761143S → P in CMD1A. 1 PublicationCorresponds to variant dbSNP:rs61661343EnsemblClinVar.1
Natural variantiVAR_017660161E → K in CMD1A. 2 PublicationsCorresponds to variant dbSNP:rs28933093EnsemblClinVar.1
Natural variantiVAR_070176166R → P in CMD1A; dramatically aberrant localization with almost no nuclear rim staining and formation of intranuclear foci. 1 PublicationCorresponds to variant dbSNP:rs267607570EnsemblClinVar.1
Natural variantiVAR_039764190R → W in CMD1A. 3 PublicationsCorresponds to variant dbSNP:rs59026483EnsemblClinVar.1
Natural variantiVAR_039765192D → G in CMD1A; dramatically increases the size of intranuclear speckles and reduces their number; this phenotype is only partially reversed by coexpression of the G-192 mutation and wild-type lamin-C; precludes insertion of lamin-C into the nuclear envelope when co-transfected with the G-192 LMNA; G-192 lamin-C expression totally disrupts the SUMO1 pattern. 1 PublicationCorresponds to variant dbSNP:rs57045855EnsemblClinVar.1
Natural variantiVAR_009977195N → K in CMD1A; dramatically aberrant localization with decreased nuclear rim staining and formation of intranuclear foci; distribution of endogenous LMNA, LMNB1 and LMNB2 are altered in cells expressing this mutant; causes an increased loss of endogenous EMD from the nuclear envelope; interacts with itself and with wild-type LMNA and LMNB1; no decrease in the stability compared with wild-type. 2 PublicationsCorresponds to variant dbSNP:rs28933091EnsemblClinVar.1
Natural variantiVAR_009978203E → G in CMD1A; interacts with itself and with wild-type LMNA and LMNB1; no decrease in the stability compared with wild-type; decreased sumoylation; aberrant localization with decreased nuclear rim staining and formation of intranuclear foci; associated with increased cell death. 3 PublicationsCorresponds to variant dbSNP:rs28933092EnsemblClinVar.1
Natural variantiVAR_039767203E → K in CMD1A; decreased sumoylation; aberrant localization with decreased nuclear rim staining and formation of intranuclear foci; associated with increased cell death. 3 PublicationsCorresponds to variant dbSNP:rs61195471EnsemblClinVar.1
Natural variantiVAR_070177210I → S in CMD1A; dramatically aberrant localization with almost no nuclear rim staining and increased formation of intranuclear foci. 1 PublicationCorresponds to variant dbSNP:rs267607572EnsemblClinVar.1
Natural variantiVAR_039768215L → P in CMD1A; aberrant localization with decreased nuclear rim staining and formation of intranuclear foci. 2 PublicationsCorresponds to variant dbSNP:rs61295588EnsemblClinVar.1
Natural variantiVAR_039775317E → K in CMD1A. 2 PublicationsCorresponds to variant dbSNP:rs56816490EnsemblClinVar.1
Natural variantiVAR_070179318A → T in CMD1A; no effect on nuclear morphology and lamin A localization. 1 PublicationCorresponds to variant dbSNP:rs267607574EnsemblClinVar.1
Natural variantiVAR_039776349R → L in CMD1A. 1 PublicationCorresponds to variant dbSNP:rs58789393EnsemblClinVar.1
Natural variantiVAR_070180388R → H in CMD1A; no effect on nuclear morphology but restricts lamin A to the cytoplasm. 1 PublicationCorresponds to variant dbSNP:rs267607576EnsemblClinVar.1
Natural variantiVAR_039779435R → C in CMD1A. 1 PublicationCorresponds to variant dbSNP:rs150840924EnsemblClinVar.1
Natural variantiVAR_070182471R → H in CMD1A; no effect on nuclear morphology and lamin A localization. 1 PublicationCorresponds to variant dbSNP:rs267607578EnsemblClinVar.1
Natural variantiVAR_067258523G → R in CMD1A. 1 PublicationCorresponds to variant dbSNP:rs201583907EnsemblClinVar.1
Natural variantiVAR_039786541R → C in CMD1A; grossly abnormal nuclear shape with the nuclear envelope producing prominent lobules in about 10% of cultured skin fibroblasts from heterozygous patients. 3 PublicationsCorresponds to variant dbSNP:rs56984562EnsemblClinVar.1
Natural variantiVAR_039789573S → L in CMD1A, FPLD2 and MADA. 3 PublicationsCorresponds to variant dbSNP:rs60890628EnsemblClinVar.1
Lipodystrophy, familial partial, 2 (FPLD2)11 Publications
The disease is caused by mutations affecting the gene represented in this entry.
Disease descriptionA disorder characterized by the loss of subcutaneous adipose tissue in the lower parts of the body (limbs, buttocks, trunk). It is accompanied by an accumulation of adipose tissue in the face and neck causing a double chin, fat neck, or cushingoid appearance. Adipose tissue may also accumulate in the axillae, back, labia majora, and intraabdominal region. Affected patients are insulin-resistant and may develop glucose intolerance and diabetes mellitus after age 20 years, hypertriglyceridemia, and low levels of high density lipoprotein cholesterol.
See also OMIM:151660
Feature keyPosition(s)DescriptionActionsGraphical viewLength
Natural variantiVAR_03974828R → W in FPLD2. 1 PublicationCorresponds to variant dbSNP:rs59914820EnsemblClinVar.1
Natural variantiVAR_03975562R → G in FPLD2. 1 PublicationCorresponds to variant dbSNP:rs56793579EnsemblClinVar.1
Natural variantiVAR_016913133R → L in FPLD2. 1 PublicationCorresponds to variant dbSNP:rs60864230EnsemblClinVar.1
Natural variantiVAR_039770230D → N in FPLD2. 1 PublicationCorresponds to variant dbSNP:rs61214927EnsemblClinVar.1
Natural variantiVAR_070181439R → C in FPLD2; increase in nuclear blebbing and formation of honeycomb-like structures in the nuclei with no accumulation of prelamin A in skin fibroblasts; causes oligomerization of the C-terminal globular domain of lamins A and C under no-reducing conditions and increases binding affinity for DNA; increases sensitivity to oxidative stress; no significant differences in stability and structure compared with the wild-type. 1 PublicationCorresponds to variant dbSNP:rs62636506EnsemblClinVar.1
Natural variantiVAR_009989465G → D in FPLD2. 1 PublicationCorresponds to variant dbSNP:rs61282106EnsemblClinVar.1
Natural variantiVAR_009991482R → L in FPLD2; abnormal nuclear localization in a honeycomb expression pattern in about 10% of cultured skin fibroblasts from heterozygous patients; no effect on protein level. 2 PublicationsCorresponds to variant dbSNP:rs11575937EnsemblClinVar.1
Natural variantiVAR_009992482R → Q in FPLD2; interacts with itself and with wild-type LMNA and LMNB1; no decrease in the stability compared with wild-type. 3 PublicationsCorresponds to variant dbSNP:rs11575937EnsemblClinVar.1
Natural variantiVAR_009993482R → W in FPLD2; interacts with itself and with wild-type LMNA and LMNB1; no decrease in the stability compared with wild-type; decreases binding affinity for DNA; increases sensitivity to oxidative stress. 4 PublicationsCorresponds to variant dbSNP:rs57920071EnsemblClinVar.1
Natural variantiVAR_009994486K → N in FPLD2; interacts with itself and with wild-type LMNA and LMNB1; no decrease in the stability compared with wild-type. 1 PublicationCorresponds to variant dbSNP:rs59981161EnsemblClinVar.1
Natural variantiVAR_071968515K → E in FPLD2. 1 Publication1
Natural variantiVAR_009998582R → H in FPLD2. 1 PublicationCorresponds to variant dbSNP:rs57830985EnsemblClinVar.1
Limb-girdle muscular dystrophy 1B (LGMD1B)8 Publications
The disease is caused by mutations affecting the gene represented in this entry.
Disease descriptionAn autosomal dominant degenerative myopathy with age-related atrioventricular cardiac conduction disturbances, dilated cardiomyopathy, and the absence of early contractures. Characterized by slowly progressive skeletal muscle weakness of the hip and shoulder girdles. Muscle biopsy shows mild dystrophic changes.
See also OMIM:159001
Feature keyPosition(s)DescriptionActionsGraphical viewLength
Natural variantiVAR_034708208Missing in LGMD1B; no obvious effect on nuclear morphology in cultured skin fibroblasts from heterozygous patients; no effect on protein level. 2 Publications1
Natural variantiVAR_076563259Y → C in LGMD1B. 1 Publication1
Natural variantiVAR_016205377R → H in LGMD1B; no obvious effect on nuclear morphology in cultured skin fibroblasts from heterozygous patients; no effect on protein level. 6 PublicationsCorresponds to variant dbSNP:rs61672878EnsemblClinVar.1
Natural variantiVAR_039783481Y → H in LGMD1B. 1 PublicationCorresponds to variant dbSNP:rs57747780EnsemblClinVar.1
Charcot-Marie-Tooth disease 2B1 (CMT2B1)1 Publication
The disease is caused by mutations affecting the gene represented in this entry.
Disease descriptionA recessive axonal form of Charcot-Marie-Tooth disease, a disorder of the peripheral nervous system, characterized by progressive weakness and atrophy, initially of the peroneal muscles and later of the distal muscles of the arms. Charcot-Marie-Tooth disease is classified in two main groups on the basis of electrophysiologic properties and histopathology: primary peripheral demyelinating neuropathies (designated CMT1 when they are dominantly inherited) and primary peripheral axonal neuropathies (CMT2). Neuropathies of the CMT2 group are characterized by signs of axonal degeneration in the absence of obvious myelin alterations, normal or slightly reduced nerve conduction velocities, and progressive distal muscle weakness and atrophy.
See also OMIM:605588
Feature keyPosition(s)DescriptionActionsGraphical viewLength
Natural variantiVAR_017661298R → C in CMT2B1. 1 PublicationCorresponds to variant dbSNP:rs59885338EnsemblClinVar.1
Hutchinson-Gilford progeria syndrome (HGPS)10 Publications
The disease is caused by mutations affecting the gene represented in this entry. HGPS is caused by the toxic accumulation of a truncated form of lamin-A/C. This mutant protein, called progerin (isoform 6), acts to deregulate mitosis and DNA damage signaling, leading to premature cell death and senescence. The mutant form is mainly generated by a silent or missense mutation at codon 608 of prelamin A that causes activation of a cryptic splice donor site, resulting in production of isoform 6 with a deletion of 50 amino acids near the C terminus. Progerin lacks the conserved ZMPSTE24/FACE1 cleavage site and therefore remains permanently farnesylated. Thus, although it can enter the nucleus and associate with the nuclear envelope, it cannot incorporate normally into the nuclear lamina (PubMed:12714972).1 Publication
Disease descriptionRare genetic disorder characterized by features reminiscent of marked premature aging.
See also OMIM:176670
Feature keyPosition(s)DescriptionActionsGraphical viewLength
Natural variantiVAR_070175138E → K in HGPS; might be associated with early and severe strokes. 1 PublicationCorresponds to variant dbSNP:rs267607649EnsemblClinVar.1
Natural variantiVAR_017658140L → R in HGPS; phenotype originally designated as atypical Werner syndrome. 1 PublicationCorresponds to variant dbSNP:rs60652225EnsemblClinVar.1
Natural variantiVAR_034707143S → F in HGPS. 1 PublicationCorresponds to variant dbSNP:rs58912633EnsemblClinVar.1
Natural variantiVAR_017659145E → K in HGPS; atypical. 1 PublicationCorresponds to variant dbSNP:rs60310264EnsemblClinVar.1
Natural variantiVAR_070178300D → G in HGPS; atypical form with late onset; abnormal nuclear morphology with single or multple blebs, lobulation and occasional ringed or donut shaped nuclei. 1 PublicationCorresponds to variant dbSNP:rs79907212EnsemblClinVar.1
Natural variantiVAR_017662471R → C in HGPS. 1 PublicationCorresponds to variant dbSNP:rs28928902EnsemblClinVar.1
Natural variantiVAR_017663527R → C in HGPS. 1 PublicationCorresponds to variant dbSNP:rs57318642EnsemblClinVar.1
Natural variantiVAR_034710542K → N in HGPS. 1 PublicationCorresponds to variant dbSNP:rs56673169EnsemblClinVar.1
Natural variantiVAR_017664608G → S in HGPS; reduced binding to SUN1; may affect splicing by activating a cryptic splice donor site. 3 PublicationsCorresponds to variant dbSNP:rs61064130EnsemblClinVar.1
Cardiomyopathy, dilated, with hypergonadotropic hypogonadism (CMDHH)3 Publications
The disease is caused by mutations affecting the gene represented in this entry.
Disease descriptionA disorder characterized by the association of genital anomalies, hypergonadotropic hypogonadism and dilated cardiomyopathy. Patients can present other variable clinical manifestations including mental retardation, skeletal anomalies, scleroderma-like skin, graying and thinning of hair, osteoporosis. Dilated cardiomyopathy is characterized by ventricular dilation and impaired systolic function, resulting in congestive heart failure and arrhythmia.
See also OMIM:212112
Feature keyPosition(s)DescriptionActionsGraphical viewLength
Natural variantiVAR_01765657A → P in CMDHH; phenotype originally designated as atypical Werner syndrome. 1 PublicationCorresponds to variant dbSNP:rs28928903EnsemblClinVar.1
Natural variantiVAR_06405559L → R in CMDHH. 2 PublicationsCorresponds to variant dbSNP:rs58922911EnsemblClinVar.1
Mandibuloacral dysplasia with type A lipodystrophy (MADA)3 Publications
The disease is caused by mutations affecting the gene represented in this entry.
Disease descriptionA disorder characterized by mandibular and clavicular hypoplasia, acroosteolysis, delayed closure of the cranial suture, progeroid appearance, partial alopecia, soft tissue calcinosis, joint contractures, and partial lipodystrophy with loss of subcutaneous fat from the extremities. Adipose tissue in the face, neck and trunk is normal or increased.
See also OMIM:248370
Feature keyPosition(s)DescriptionActionsGraphical viewLength
Natural variantiVAR_018727527R → H in MADA. 1 PublicationCorresponds to variant dbSNP:rs57520892EnsemblClinVar.1
Natural variantiVAR_034709529A → V in MADA. 1 PublicationCorresponds to variant dbSNP:rs60580541EnsemblClinVar.1
Lethal tight skin contracture syndrome (LTSCS)1 Publication
The disease is caused by mutations affecting the gene represented in this entry.
Disease descriptionRare disorder mainly characterized by intrauterine growth retardation, tight and rigid skin with erosions, prominent superficial vasculature and epidermal hyperkeratosis, facial features (small mouth, small pinched nose and micrognathia), sparse/absent eyelashes and eyebrows, mineralization defects of the skull, thin dysplastic clavicles, pulmonary hypoplasia, multiple joint contractures and an early neonatal lethal course. Liveborn children usually die within the first week of life. The overall prevalence of consanguineous cases suggested an autosomal recessive inheritance.
See also OMIM:275210
Heart-hand syndrome Slovenian type (HHS-Slovenian)1 Publication
The disease is caused by mutations affecting the gene represented in this entry.
Disease descriptionHeart-hand syndrome (HHS) is a clinically and genetically heterogeneous disorder characterized by the co-occurrence of a congenital cardiac disease and limb malformations.
See also OMIM:610140
Muscular dystrophy congenital LMNA-related (MDCL)1 Publication
The disease is caused by mutations affecting the gene represented in this entry.
Disease descriptionA form of congenital muscular dystrophy. Patients present at birth, or within the first few months of life, with hypotonia, muscle weakness and often with joint contractures.
See also OMIM:613205
Feature keyPosition(s)DescriptionActionsGraphical viewLength
Natural variantiVAR_063590302L → P in MDCL. 1 PublicationCorresponds to variant dbSNP:rs267607596EnsemblClinVar.1
Natural variantiVAR_063591380L → S in MDCL. 1 PublicationCorresponds to variant dbSNP:rs121912495EnsemblClinVar.1
Natural variantiVAR_063592453R → P in MDCL. 1 PublicationCorresponds to variant dbSNP:rs267607598EnsemblClinVar.1
Natural variantiVAR_063593455R → P in MDCL. 1 PublicationCorresponds to variant dbSNP:rs267607597EnsemblClinVar.1
Natural variantiVAR_063594456N → D in MDCL. 1 PublicationCorresponds to variant dbSNP:rs267607599EnsemblClinVar.1
Defects in LMNA may cause a late-onset cardiocutaneous progeria syndrome characterized by cutaneous manifestations of aging appearing in the third decade of life, cardiac valve calcification and dysfunction, prominent atherosclerosis, and cardiomyopathy, leading to death on average in the fourth decade.1 Publication

Mutagenesis

Feature keyPosition(s)DescriptionActionsGraphical viewLength
<p>This subsection of the <a href="http://www.uniprot.org/manual/pathology_and_biotech_section">'Pathology and Biotech'</a> section describes the effect of the experimental mutation of one or more amino acid(s) on the biological properties of the protein.<p><a href='/help/mutagen' target='_top'>More...</a></p>Mutagenesisi201K → L: Decreased sumoylation; aberrant localization with decreased nuclear rim staining and formation of intranuclear foci; associated with increased cell death. 1 Publication1
Mutagenesisi644R → A: Does not affect tail cleavage. 1 Publication1
Mutagenesisi647L → R: Completely inhibits tail cleavage. 1 Publication1
Mutagenesisi648L → A: Completely inhibits tail cleavage. 1 Publication1
Mutagenesisi650N → A: Partially inhibits tail cleavage. 1 Publication1
Mutagenesisi661C → S: Loss of interaction with NARF. Abolishes farnesylation. 2 Publications1

Keywords - Diseasei

Cardiomyopathy, Charcot-Marie-Tooth disease, Congenital muscular dystrophy, Disease mutation, Emery-Dreifuss muscular dystrophy, Limb-girdle muscular dystrophy, Neurodegeneration, Neuropathy

Organism-specific databases

DisGeNET

More...DisGeNETi		4000

GeneReviews a resource of expert-authored, peer-reviewed disease descriptions.

More...GeneReviewsi		LMNA

MalaCards human disease database

More...MalaCardsi		LMNA
MIMi115200 phenotype
151660 phenotype
159001 phenotype
176670 phenotype
181350 phenotype
212112 phenotype
248370 phenotype
275210 phenotype
605588 phenotype
610140 phenotype
613205 phenotype
616516 phenotype

Open Targets

More...OpenTargetsi		ENSG00000160789

Orphanet; a database dedicated to information on rare diseases and orphan drugs

More...Orphaneti		79474 Atypical Werner syndrome
98853 Autosomal dominant Emery-Dreifuss muscular dystrophy
264 Autosomal dominant limb-girdle muscular dystrophy type 1B
98855 Autosomal recessive Emery-Dreifuss muscular dystrophy
280365 Autosomal semi-dominant severe lipodystrophic laminopathy
98856 Charcot-Marie-Tooth disease type 2B1
157973 Congenital muscular dystrophy due to LMNA mutation
2229 Dilated cardiomyopathy-hypergonadotropic hypogonadism syndrome
300751 Familial dilated cardiomyopathy with conduction defect due to LMNA mutation
293899 Familial isolated arrhythmogenic ventricular dysplasia, biventricular form
293888 Familial isolated arrhythmogenic ventricular dysplasia, left dominant form
293910 Familial isolated arrhythmogenic ventricular dysplasia, right dominant form
2348 Familial partial lipodystrophy, Dunnigan type
79084 Familial partial lipodystrophy, Koebberling type
168796 Heart-hand syndrome, Slovenian type
740 Hutchinson-Gilford progeria syndrome
54260 Left ventricular noncompaction
363618 LMNA-related cardiocutaneous progeria syndrome
90153 Mandibuloacral dysplasia with type A lipodystrophy
1662 Restrictive dermopathy

The Pharmacogenetics and Pharmacogenomics Knowledge Base

More...PharmGKBi		PA231

Chemistry databases

ChEMBL database of bioactive drug-like small molecules

More...ChEMBLi		CHEMBL1293235

Polymorphism and mutation databases

BioMuta curated single-nucleotide variation and disease association database

More...BioMutai		LMNA

Domain mapping of disease mutations (DMDM)

More...DMDMi		125962

<p>This section describes post-translational modifications (PTMs) and/or processing events.<p><a href='/help/ptm_processing_section' target='_top'>More...</a></p>PTM / Processingi

Molecule processing

Feature keyPosition(s)DescriptionActionsGraphical viewLength
<p>This subsection of the ‘PTM / Processing’ section describes the extent of a polypeptide chain in the mature protein following processing.<p><a href='/help/chain' target='_top'>More...</a></p>ChainiPRO_00003988351 – 661Prelamin-A/CAdd BLAST661
ChainiPRO_00000638101 – 646Lamin-A/CAdd BLAST646
<p>This subsection of the <a href="http://www.uniprot.org/help/ptm_processing_section">PTM / Processing</a> section describes a propeptide, which is a part of a protein that is cleaved during maturation or activation. Once cleaved, a propeptide generally has no independent biological function.<p><a href='/help/propep' target='_top'>More...</a></p>PropeptideiPRO_0000398836647 – 661Removed in Lamin-A/C formAdd BLAST15
PropeptideiPRO_0000403442662 – 664Removed in Prelamin-A/C form and in Lamin-A/C form3

Amino acid modifications

Feature keyPosition(s)DescriptionActionsGraphical viewLength
<p>This subsection of the ‘PTM / Processing’ section specifies the position and type of each modified residue excluding <a href="http://www.uniprot.org/manual/lipid">lipids</a>, <a href="http://www.uniprot.org/manual/carbohyd">glycans</a> and <a href="http://www.uniprot.org/manual/crosslnk">protein cross-links</a>.<p><a href='/help/mod_res' target='_top'>More...</a></p>Modified residuei1N-acetylmethionineCombined sources1
Modified residuei3PhosphothreonineCombined sources1
Modified residuei12PhosphoserineCombined sources1
Modified residuei18PhosphoserineCombined sources1
Modified residuei19PhosphothreonineCombined sources1
Modified residuei22PhosphoserineCombined sources1 Publication1
Modified residuei32N6-acetyllysine; alternateBy similarity1
Modified residuei32N6-succinyllysine; alternateBy similarity1
<p>This subsection of the <a href="http://www.uniprot.org/help/ptm_processing_section">PTM / Processing</a> section describes <strong>covalent linkages</strong> of various types formed <strong>between two proteins (interchain cross-links)</strong> or <strong>between two parts of the same protein (intrachain cross-links)</strong>, except the disulfide bonds that are annotated in the <a href="http://www.uniprot.org/manual/disulfid">'Disulfide bond'</a> subsection.<p><a href='/help/crosslnk' target='_top'>More...</a></p>Cross-linki32Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternateCombined sources
Modified residuei51PhosphoserineCombined sources1
Modified residuei66PhosphoserineCombined sources1
Modified residuei71PhosphoserineCombined sources1
Cross-linki97Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)Combined sources
Modified residuei107PhosphoserineCombined sources1
Modified residuei108N6-acetyllysineCombined sources1
Modified residuei123N6-acetyllysineBy similarity1
Modified residuei135N6-acetyllysineBy similarity1
Modified residuei155N6-acetyllysineBy similarity1
Modified residuei171N6-acetyllysine; alternateBy similarity1
Modified residuei171N6-succinyllysine; alternateBy similarity1
Cross-linki171Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternateCombined sources
Modified residuei201N6-acetyllysine; alternateBy similarity1
Cross-linki201Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO); alternate
Cross-linki201Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternateCombined sources
Cross-linki208Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)Combined sources
Modified residuei212PhosphoserineCombined sources1
Cross-linki219Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)Combined sources
Cross-linki233Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)Combined sources
Modified residuei260N6-acetyllysine; alternateBy similarity1
Cross-linki260Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternateCombined sources
Modified residuei270N6-acetyllysine; alternateCombined sources1
Cross-linki270Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternateCombined sources
Modified residuei277PhosphoserineCombined sources1
Modified residuei301PhosphoserineCombined sources1
Modifi